Short-Term Outcomes in Children with multisystem inflammatory syndrome associated with SARS-COV2 Infection

Document Type : Original Article

Authors

1 Pediatrics Department, Faculty of Medicine, Beni-Suef University, Egypt

2 Clinical pathology department, Faculty of Medicine, Beni-Suef University, Egypt

Abstract

Background and aims: Signs of inflammation and multi organ dysfunction describe a novel clinical disorder called multisystem inflammatory syndrome in children (MIS-C), which is caused by the cytokine storm correlated with SARS-CoV-2. This study aimed to follow up with children with MIS- C correlated with SARS-COV2 infection to determine any sequalae or delayed manifestation of MIS-C. Methods: Children less than 18 years old with a diagnosis of MIS-C were included in this prospective research at the Beni-Suef University Hospital. Comparative analyses of admission and po st discharge clinical and laboratory parameters were performed. Results: Fifty-three children were involved in the research from March 2022 to July 2022 with a mean age of 5.08 ±4.05 years. Fourteen o f the youngsters already had chronic systemic comorbidity. The presence of fever was observed in every case. The hematological (92.45%), GIT, and neurological (56.6%) systems were the most affected. Mo rtality is significantly higher among children with young age, chronic illness, and MIS- C clinical presentation overlapping with COVID-19 infection. Lymphopenia and thrombocytopenia were more common among dead than survivor patients. Conclusions: The prognosis is good for children with no underlying medical conditions. Low lymp hocyte counts and elevated troponin levels may be unfavorable indicators of survival. Positive follow-up results in coronary care were reported.

Keywords

Main Subjects

References

  1. Belhadjer Z, Méot M, Bajolle F. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation, 2020; 142:429–436.
  2. Patel JM. Multisystem Inflammatory Syndrome in Children (MIS-C). Curr Allergy Asthma Rep., 2022; 22(5):53-60.
  3. Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic Eur J Pediatr, 2021;180, 2019-2034.
  4. Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. Multisystem
    Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis. Front Immunol. 2022; 7; 13:941009.
  5. Sperotto F, Friedman KG, Son MBF. Cardiac manifestations in SARS-CoV-2- associated multisystem inflammatory
    syndrome in children: a comprehensive review and proposed clinical approach. Eur J , 2021; 180:307–322.
  6. Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, et al. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med , 2020;92(10):1902–1914.
  7. Rowley AH, Shulman ST, Arditi M. Immune pathogenesis of COVID-19 related multisystem inflammatory syndrome in J Clin Invest, 2020; 130:5619– 11.5621.
  8. García-Salido A, de Carlos Vicente JC, Belda Hofheinz S. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicenter study in pediatric intensive care units in Spain. Crit Care, 2020; 24, 666.
  9. Patnaik S, Jain MK, Ahmed S, Dash AK, Sahoo B, Mishra R, et al. Short-term outcomes in children recovered from multisystem inflammatory syndrome
    associated with SARS-CoV-2 infection. Rheumatol Int. 2021 Nov; 41(11):1957-
  10. Yilmaz Ciftdogan D, Ekemen Keles Y, Cetin BS, et al. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group. Eur J Pediatr, 2022; 181, 2031–
  11. Awasthi P, Vijay K, Sanjeev N, Karthi N, Suresh K, Arun B, et al. Multisystem Inflammatory Syndrome in Children: Follow-Up of a Cohort from North India, 2022; 106(4): 1108–
  12. Penner J. 6-month multidisciplinary follow-up and outcomes of patients with the pediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary pediatric hospital: a retrospective cohort Lancet Child Adolescent Health, 2021; 5: 473–482.
  13. Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB. Characteristics and outcomes of US children and adolescents with the multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA, 2021; 325: 1074–
  14. Farooqi KM. Longitudinal outcomes for multisystem inflammatory syndrome in Pediatrics, 2021;
    148: e2021051155.
  15. Tiwari A, Balan S, Rauf A, Kappanayil M, Kesavan S. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a hospital-based prospective cohort study from Kerala, India. BMJ Paediatr Open, 2021; 18: 5(1):001195.

Files

Share

How to cite

Statistics